$ABEV

Ambev (ABEV) Q2 2026 Earnings Call Transcript

Thursday, July 30, 2026 at 4:00 a.m. ET CALL PARTICIPANTS CEO - Carlos Eduardo Lisboa CFO and Investor Relations Officer - Guilherme Fleury de Figueiredo Parolari TAKEAWAYS Normalized EBITDA -- BRL 6.4 billion, representing 8.9% growth and 80 basis points of margin expansion driven by disciplined decisions across cost and revenue management. Normalized EPS -- BRL 0.22, a 24.2% increase compared to the previous year, supported by improved operating results and lower net financial expenses.

Original reporting
Published Jul 31, 2026, 2:00 AM UTC
Analysis
alphai AI DeskAI-generated
Added to alphai Jul 31, 2026, 2:41 AM UTC. Informational, not investment advice.
How this was made
alphai summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
Ambev (ABEV) Q2 2026 Earnings Call Transcript — source image
Decision brief

The 30-second read

$ABEVBullishMed
01

Why it matters

The disclosed metrics support a constructive read-through on operating leverage and cash generation, while management’s risk notes (FX translation, Brazil NAB recovery timing, consumer debt) flag potential near-term earnings volatility.

02

Market read

Traders can update expectations for Ambev’s margin trajectory, cash generation, and segment mix, while monitoring FX and Brazil non-alcohol demand risks.

03

What to watch

Brazil NAB volumes declined 4.4% and management cited elevated household debt; these could limit demand recovery even if premium and balanced choices remain strong.

Relevance 7/10Novelty 6/10Timing: earnings call transcript released pre-market July 31

Background

This is a transcript of Ambev’s 2026 Q2 earnings call, covering normalized profitability, volumes by segment, cash flow, and shareholder returns.

Company-level read

Ticker impact

$ABEVBullishMedium confidence
Context

Ambev reported Q2 normalized EBITDA of BRL 6.4B (+8.9%) and normalized EPS of BRL 0.22 (+24.2%) on the earnings call.

Expected impact

Near-term bias modestly positive, with volatility risk tied to FX translation and non-alcohol volume trends.

Evidence & confidence

The article discloses multiple quantified operating and financial metrics (EBITDA, EPS, cash flow, buyback execution) plus explicit risk commentary on Bolivian FX devaluation and Brazil NAB volume decline.

Market effects

Highlights ongoing premium and non-alcohol category mix shifts in LatAm beer, with digital marketplace GMV growth as a monetization lever.

Emphasizes Brazil consumer debt sensitivity and Bolivia logistics disruption, both of which can affect volumes and reported results.

Shows how FX translation and regional macro conditions can swing reported financials for multinational beverage peers.

Counterpoint

Reported EPS and EBITDA growth may be partly influenced by non-cash items (e.g., FX reserve conversion gains), which could fade and pressure forward earnings quality.

Key entities

  • Ambev

    Brazilian beverage company reporting Q2 2026 normalized EBITDA, EPS, volumes, cash flow, and buyback execution.

  • Carlos Eduardo Lisboa

    CEO who discussed premium/balanced growth, FIFA World Cup activation strategy, and Ze Delivery performance.

  • Guilherme Fleury de Figueiredo Parolari

    CFO who cited margin expansion drivers, cash flow improvement, and FX-related financial expense dynamics.

Related articles

$DGHighAI 9/10

Dollar General gets Q2 boost from tariff refunds, delivery

Dollar General reported Q2 net income rose 33.8% to $550.3M, with sales up 5.2% to $11.3B, driven by tariff refunds and delivery growth. The company raised its full-year outlook, now expecting sales growth of 4% to 4.3% and EPS of $7.80 to $8.00. It also expanded its $1 Value Valley sections to 9,000 stores, boosting comp-store sales.

$WSMMedAI 8/10

Williams-Sonoma Tops Gordon Haskett’s Home Vertical Rankings

Gordon Haskett ranked Williams-Sonoma (WSM) top in the home vertical sector, citing strong Q2 results and improved outlook. The firm maintained a Buy rating with a $260 price target, based on 24x fiscal 2027 EPS estimate of $10.75. WSM reported Q2 revenue of $1.96B and EPS of $2.10, with same-store sales up 6.2% and operating margin at 17.3%. The company raised fiscal 2026 guidance for same-store sales and operating margin.

$DYHigh

Why Dycom Industries Stock Is Plummeting This Week

Dycom Industries (NYSE: DY) reported Q2 2027 revenue of $2.01B, beating estimates, but its adjusted EBITDA margin shrank to 13.6% from 14.9% YoY. Analysts like KeyBanc and Cantor Fitzgerald lowered price targets. Shares fell 21.6% this week. The company's backlog grew to $12.2B, and free cash flow rose to $37.9B.

$PLABHighAI 8/10

Photronics (PLAB) Crushed Earnings Estimates, Then The Stock Gave It Back

Photronics (PLAB) reported fiscal Q3 revenue of $216.0M, beating estimates, with adjusted earnings of $0.50 per share. Despite an initial 27.1% stock surge, shares settled up only 4%. High-end IC business revenue rose 5% YoY, reaching a record 44% of total IC revenue. Guidance for Q4 revenue is $207M-$227M, with adjusted earnings per share ranging from $0.48 to $0.56. Short interest is at 10.61% of the float, indicating significant bearish sentiment.

$BBYHigh

Could tech startups rescue rural healthcare?

Best Buy raised its fiscal year outlook after reporting a 4.1% increase in comparable sales in Q2. Meanwhile, states are investing in tech startups to address rural healthcare challenges, despite the unproven nature of these companies.